Moderna's 2017 Influenza Vaccine Study and Lipid Nanoparticle Distribution

And that's not the only paper you should know about,

because in 2017, Moderna published a paper using lipid nanoparticles on the influenza vaccine,

and it showed that when the animals tested,

their lipid nanoparticle vaccine spread into the brain,

the bone marrow, the liver, the spleen, and the muscle site

where it was injected.

2017, brought to you by Moderna.